Seshu Tyagarajan, Chief Technology Officer at Candel Therapeutics, Inc. (CADL), sold 7,000 shares at $12.00 ($84K) on 2026-08-17, disclosed to the SEC on 2026-08-19.
Scheduled sale ($84k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CADL | SELL | 2025-01-17 | $207K | — | Filing → |
| CADL | SELL | 2025-01-10 | $239K | — | Filing → |
| CADL | SELL | 2024-12-03 | $186K | — | Filing → |